OptiNose(OPTN) - 2024 Q4 - Annual Results

Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 8-K ____________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2025 __________________________________________________________________________________________ OPTINOSE, INC. (Exact Name of Registrant as Specif ...